Stimulant prescriptions for adult ADHD have more than doubled since the onset of the COVID-19 pandemic, raising concerns among healthcare professionals about the implications of this trend.
Adult ADHD treatment has seen a significant surge, with stimulant prescriptions more than doubling since the COVID-19 pandemic began. A new Canadian study highlights this dramatic healthcare trend, which is reflected in similar increases observed in the United States, Australia, the United Kingdom, and Finland.
According to the study, which analyzed data from January 2016 to June 2024, adults are seeking ADHD treatment at unprecedented rates. The demographics of those receiving stimulant prescriptions have shifted notably; prior to the pandemic, 48% of new recipients were female, but that figure rose to 59% during the pandemic. The most substantial growth was observed among adults aged 25 to 34.
The research also noted that the time between a patient’s first ADHD-related healthcare visit and their first prescription has decreased during the pandemic. By June 2024, the monthly rate of adults prescribed stimulants reached 10.4 per 1,000 people, marking a more than sevenfold increase since the beginning of the study period.
While this trend may indicate more efficient care, it raises concerns about the thoroughness of patient evaluations. Dr. Nissa Keyashian, a California-based board-certified psychiatrist and author of “Practicing Stillness,” expressed that the spike in diagnoses was not unexpected. “In my practice and that of many of my colleagues, many people, particularly women, have received a new diagnosis of ADHD, usually inattentive subtype, in adulthood,” Keyashian, who was not involved in the study, told Fox News Digital.
Keyashian explained that many of these women had symptoms overlooked during childhood. Unlike the hyperactive or impulsive behaviors often seen in boys, the inattentive subtype typically causes fewer disruptions at home or school. “Many only begin to struggle when they move out, are on their own, and have to provide that structure for themselves,” she noted.
Jonathan Alpert, a New York City psychotherapist and author of “Therapy Nation,” reported seeing many adult patients grappling with focus, productivity, and mental overload in a demanding digital environment. “Those challenges can resemble ADHD, but they don’t always reflect an actual diagnosis,” Alpert, who also wasn’t involved in the research, stated. “Not every attention problem is ADHD.” He further emphasized that society is increasingly pathologizing normal human difficulties, which he believes is concerning.
The study also revealed a shift in who is prescribing these medications. While the number of stimulants prescribed by psychiatrists remained relatively stable, there was a notable increase in prescriptions from primary care providers and nurse practitioners. The rise of large telehealth companies during the pandemic may have contributed to this trend, as it could have led to an uptick in diagnoses for individuals who may not actually have ADHD.
Alpert cautioned against the misuse of medication, stating, “Medication should treat a disorder, not become a performance enhancer. Over time, that can lead to psychological reliance and reinforce the idea that normal struggles require medical solutions.”
The researchers acknowledged some limitations of their study, including a lack of access to detailed medical records and uncertainty about whether their findings apply universally across geographic regions. They also noted that some stimulants may have been prescribed off-label as adjunctive treatments for depression or anxiety, conditions that surged during the pandemic.
For individuals who suspect they may have ADHD, Keyashian recommends consulting a psychiatrist with expertise in the diagnosis. “It’s best to ask the physician you are seeing about their experience and expertise,” she advised.
Alpert added, “Many people today feel mentally scattered. The challenge is figuring out whether we’re seeing more of the disorder — or simply the cognitive strain of a hyper-distracted world.” The research was published in the Canadian Medical Association Journal, shedding light on this evolving landscape of adult ADHD treatment.
According to Fox News Digital, the implications of this surge in stimulant prescriptions warrant careful consideration from both healthcare providers and patients alike.